NO DIFFERENCES IN GI BLEEDING RISK BETWEEN CLOPIDOGREL-, TICAGRELOR- OR PRASUGREL-BASED DUAL ANTIPLATELET THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION

Viviana Laredo De La Torre  1     Sandra Garcia Mateo  1     Alba Barberan Bernardos  2     Javier Velázquez Ortigas  2     Pablo Revilla Marti  3     Patricia Carrera-Lasfuentes  4     Carlos Sostres Homedes     Angel Lanas    
1 Hospital Clínico Lozano Blesa,Zaragoza,Spain
2 University of Zaragoza University Hospital Dept. of Medicine-Gastroenterology,Zaragoza,Spain
3 Hospital Clinico Lozano Blesa,Zaragoza,Spain
4 CIBERehd,M

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing